Zobrazeno 1 - 10
of 885
pro vyhledávání: '"Borderline ovarian tumors"'
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 9, Pp 19-23 (2024)
In recent decades, the attention of the medical community has increasingly focused on the problems associated with ovarian tumors, especially on the differentiation/difference between borderline tumors and ovarian cancer. These two conditions not onl
Externí odkaz:
https://doaj.org/article/fff0ffc077084d608c58e3883d1cbae2
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 7, Pp 83-90 (2024)
Borderline ovarian tumors were first infected about 100 years ago. They are detected at an early stage and have a favorable outcome. But, as is known, relapse can begin within 20 years after therapy. Most often they occur in young women who are still
Externí odkaz:
https://doaj.org/article/2534147c63d5434daac177a82afdf482
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Associations between different cancer types are known. The affirmation of the risk for non-ovarian cancer after ovarian borderline tumors (BOT) is, however, sparse. Aim To analyze the risk of subsequent or simultaneous cancers in
Externí odkaz:
https://doaj.org/article/c26a41ab67a346fbb544aa575a092ff9
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-8 (2023)
Abstract Objective To investigate whether the ultrasound microcystic pattern (MCP) can accurately predict borderline ovarian tumors (BOTs). Methods A retrospective collection of 393 patients who met the inclusion criteria was used as the study popula
Externí odkaz:
https://doaj.org/article/6fff77cd6d254a3ba24f6d62c197d901
Autor:
D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 303-316 (2023)
Patients who underwent radical antitumor treatment for ovarian cancer, borderline ovarian tumors, often experience a severe range of morphofunctional and psychological disorders. Frequent complications are postovariectomy syndrome, sexual dysfunction
Externí odkaz:
https://doaj.org/article/bc4b5b00060b45808196983692e688ce
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 44-51 (2022)
Purpose of the study: to assess the relationship between atypical/hybrid forms of EpCAM+CD45+ cells in ascitic fluid of ovarian cancer patients and the levels of cancer markers, such as CA125 and HE4, and the tumor grade. Material and methods. The st
Externí odkaz:
https://doaj.org/article/2f4f14a4daae4774b8022d951b47bc81
Publikováno v:
Gynecologic Oncology Reports, Vol 47, Iss , Pp 101180- (2023)
Objectives: Adjuvant management of borderline ovarian tumors (BOT) after surgical diagnosis and staging is not standardized. While many patients undergo observation alone, some providers have introduced the use of adjuvant antihormonal therapy for BO
Externí odkaz:
https://doaj.org/article/574a36f32b2f407eb4e6f1528f7efcbf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Svetlana S. Lukina, Alexey M. Burdennyy, Elena A. Filippova, Irina V. Pronina, Tatiana P. Kazubskaya, Dmitry N. Kushlinsky, Dmitriy O. Utkin, Eleonora A. Braga, Vitaly I. Loginov, Nikolay E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 50, Iss 1, Pp 21-30 (2022)
Background: Borderline ovarian tumors (BOT) belong to the intermediate type between benign and malignant ovarian neoplasms. Serous borderline tumors share common molecular and genetic characteristics with serous carcinomas. An increase in the methyla
Externí odkaz:
https://doaj.org/article/9fb39d7cafc74d29843f2bdcc62f6a49